Perioperative durvalumab with neoadjuvant chemotherapy in operable bladder cancer

Powles, T., Catto, J.W.F. orcid.org/0000-0003-2787-8828, Galsky, M.D. et al. (22 more authors) (2024) Perioperative durvalumab with neoadjuvant chemotherapy in operable bladder cancer. New England Journal of Medicine, 391 (19). pp. 1773-1786. ISSN 0028-4793

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024 Massachusetts Medical Society

Keywords: Adult; Aged; Female; Humans; Male; Middle Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Gemcitabine; Kaplan-Meier Estimate; Neoadjuvant Therapy; Progression-Free Survival; Survival Analysis; Urinary Bladder Neoplasms; Antineoplastic Agents, Immunological; Aged, 80 and over
Dates:
  • Published: 14 November 2024
  • Published (online): 15 September 2024
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 18 Mar 2025 15:53
Last Modified: 18 Mar 2025 15:53
Status: Published
Publisher: Massachusetts Medical Society
Refereed: Yes
Identification Number: 10.1056/nejmoa2408154
Related URLs:
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics